These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 31298366)
1. MiR-506-3p acts as a novel tumor suppressor in prostate cancer through targeting GALNT4. Hu CY; You P; Zhang J; Zhang H; Jiang N Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5133-5138. PubMed ID: 31298366 [TBL] [Abstract][Full Text] [Related]
2. The putative tumour suppressor miR-1-3p modulates prostate cancer cell aggressiveness by repressing E2F5 and PFTK1. Li SM; Wu HL; Yu X; Tang K; Wang SG; Ye ZQ; Hu J J Exp Clin Cancer Res; 2018 Sep; 37(1):219. PubMed ID: 30185212 [TBL] [Abstract][Full Text] [Related]
4. miR-326 functions as a tumor suppressor in human prostatic carcinoma by targeting Mucin1. Liang X; Li Z; Men Q; Li Y; Li H; Chong T Biomed Pharmacother; 2018 Dec; 108():574-583. PubMed ID: 30243091 [TBL] [Abstract][Full Text] [Related]
5. miR-490-3p modulates the progression of prostate cancer through regulating histone deacetylase 2. Fan H; Zhang YS Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):539-546. PubMed ID: 30720161 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA-487a-3p functions as a new tumor suppressor in prostate cancer by targeting CCND1. Wang M; Yu W; Gao J; Ma W; Frentsch M; Thiel A; Liu M; Rahman N; Qin Z; Li X J Cell Physiol; 2020 Feb; 235(2):1588-1600. PubMed ID: 31309555 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA-373-3p inhibits prostate cancer progression by targeting AKT1. Qu HW; Jin Y; Cui ZL; Jin XB Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6252-6259. PubMed ID: 30338790 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-655-3p functions as a tumor suppressor by regulating ADAM10 and β-catenin pathway in Hepatocellular Carcinoma. Wu G; Zheng K; Xia S; Wang Y; Meng X; Qin X; Cheng Y J Exp Clin Cancer Res; 2016 Jun; 35(1):89. PubMed ID: 27259866 [TBL] [Abstract][Full Text] [Related]
9. miR-15a-3p Suppresses Prostate Cancer Cell Proliferation and Invasion by Targeting SLC39A7 Via Downregulating Wnt/β-Catenin Signaling Pathway. Cui Y; Yang Y; Ren L; Yang J; Wang B; Xing T; Chen H; Chen M Cancer Biother Radiopharm; 2019 Sep; 34(7):472-479. PubMed ID: 31135177 [No Abstract] [Full Text] [Related]
10. MiR-299-3p inhibits proliferation and invasion of cervical cancer cell via targeting TCF4. Yu Y; Zhao JD; Yang H Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5621-5627. PubMed ID: 31298314 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-361-3p suppresses tumor cell proliferation and metastasis by directly targeting SH2B1 in NSCLC. Chen W; Wang J; Liu S; Wang S; Cheng Y; Zhou W; Duan C; Zhang C J Exp Clin Cancer Res; 2016 May; 35():76. PubMed ID: 27164951 [TBL] [Abstract][Full Text] [Related]
12. microRNA-183-3p Inhibits Progression of Human Prostate Cancer by Downregulating High-Mobility Group Nucleosome Binding Domain 5. Li Y; He S; Zhan Y; He A; Gong Y; Ji G; Huang C; Peng D; Guan B; Li X; Zhou L DNA Cell Biol; 2019 Aug; 38(8):840-848. PubMed ID: 31314587 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-455-3p functions as a tumor suppressor by targeting eIF4E in prostate cancer. Zhao Y; Yan M; Yun Y; Zhang J; Zhang R; Li Y; Wu X; Liu Q; Miao W; Jiang H Oncol Rep; 2017 Apr; 37(4):2449-2458. PubMed ID: 28350134 [TBL] [Abstract][Full Text] [Related]
14. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion. Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-95-3p promoted the development of prostatic cancer via regulating DKK3 and activating Wnt/β-catenin pathway. Xi M; Cheng L; Hua W; Zhou YL; Gao QL; Yang JX; Qi SY Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1002-1011. PubMed ID: 30779066 [TBL] [Abstract][Full Text] [Related]
16. MiR-574-3p exerts as a tumor suppressor in ovarian cancer through inhibiting MMP3 expression. Zheng J; Zhou Y; Li XJ; Hu JM Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6839-6848. PubMed ID: 31486483 [TBL] [Abstract][Full Text] [Related]
17. Loss of Liu Y; Liu H; Yang L; Wu Q; Liu W; Fu Q; Zhang W; Zhang H; Xu J; Gu J J Biol Chem; 2017 Feb; 292(8):3186-3200. PubMed ID: 28062574 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-127-3p acts as a tumor suppressor in epithelial ovarian cancer by regulating the BAG5 gene. Bi L; Yang Q; Yuan J; Miao Q; Duan L; Li F; Wang S Oncol Rep; 2016 Nov; 36(5):2563-2570. PubMed ID: 27571744 [TBL] [Abstract][Full Text] [Related]
19. Genetic and epigenetic silencing of mircoRNA-506-3p enhances COTL1 oncogene expression to foster non-small lung cancer progression. Guo S; Yang P; Jiang X; Li X; Wang Y; Zhang X; Sun B; Zhang Y; Jia Y Oncotarget; 2017 Jan; 8(1):644-657. PubMed ID: 27893417 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-498 promotes proliferation, migration, and invasion of prostate cancer cells and decreases radiation sensitivity by targeting PTEN. Duan XM; Liu XN; Li YX; Cao YQ; Silayiding A; Zhang RK; Wang JP Kaohsiung J Med Sci; 2019 Nov; 35(11):659-671. PubMed ID: 31332950 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]